Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
Saved in:
| Title: | Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer. |
|---|---|
| Authors: | George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC., Saad F; University of Montreal Hospital Centre, Montreal, QC, Canada., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK., Saltzstein DR; Urology San Antonio, San Antonio, TX., Tutrone R; Chesapeake Urology, Towson, MD., Bossi A; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France., Brown B; Myovant Sciences, Inc., Brisbane CA., Selby B; Myovant Sciences, Inc., Brisbane CA., Lu S; Myovant Sciences, Inc., Brisbane CA., Buckley D; Myovant Sciences, Inc., Brisbane CA., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC. |
| Source: | Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Jun; Vol. 21 (3), pp. 383-392.e2. Date of Electronic Publication: 2023 Mar 24. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0682 |
|---|---|
| DOI: | 10.1016/j.clgc.2023.03.009 |
